Cite
Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism.
MLA
Marcocci, Claudio, et al. “Cinacalcet Reduces Serum Calcium Concentrations in Patients with Intractable Primary Hyperparathyroidism.” The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 8, Aug. 2009, pp. 2766–72. EBSCOhost, https://doi.org/10.1210/jc.2008-2640.
APA
Marcocci, C., Chanson, P., Shoback, D., Bilezikian, J., Fernandez-Cruz, L., Orgiazzi, J., Henzen, C., Cheng, S., Sterling, L. R., Lu, J., & Peacock, M. (2009). Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism, 94(8), 2766–2772. https://doi.org/10.1210/jc.2008-2640
Chicago
Marcocci, Claudio, Philippe Chanson, Dolores Shoback, John Bilezikian, Laureano Fernandez-Cruz, Jacques Orgiazzi, Christoph Henzen, et al. 2009. “Cinacalcet Reduces Serum Calcium Concentrations in Patients with Intractable Primary Hyperparathyroidism.” The Journal of Clinical Endocrinology and Metabolism 94 (8): 2766–72. doi:10.1210/jc.2008-2640.